$HON

Honeywell Aerospace Q2 2026 earnings miss, cuts full-year outlook

Honeywell Aerospace reported Q2 2026 sales of $4.5B, up 5% YoY, and adjusted EBIT of $995M, down 7%, missing Wall Street expectations cited by Barron’s. Adjusted EPS was $1.87. The company cut full-year organic sales growth to 4% to 5% and adjusted EBIT to $4.35B–$4.45B, citing supply chain constraints. Backlog rose to $18.2B.

Original reporting
Published Aug 6, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Honeywell Aerospace Q2 2026 earnings miss, cuts full-year outlook — source image
Decision brief

The 30-second read

$HONBearishHigh
01

Why it matters

The key tradable change is the guidance reduction (organic sales growth, pro forma standalone adjusted EBIT, and full-year adjusted EPS) alongside a stated plan to qualify new suppliers and increase tooling investment.

02

Market read

This is a direct earnings and guidance reset with a large immediate stock reaction, driven by supply chain constraints and updated 2H/2026 outlook.

03

What to watch

The company plans supplier qualification expansion and tooling investment increases; if execution improves faster than expected, the market may over-discount the 2026 earnings impact.

Relevance 9/10Novelty 9/10Timing: post-close/early Thursday trading reaction to Q2 earnings and same-day guidance cut

Background

Honeywell Aerospace reported Q2 2026 results with supply chain constraints limiting output, then reduced full-year guidance.

Company-level read

Ticker impact

$HONBearishHigh confidence
Context

Honeywell Aerospace shares fell 21% after Q2 results missed expectations and the company cut full-year organic sales and EBIT guidance due to supply constraints.

Expected impact

Bearish bias for the next several sessions as traders reprice 2026 earnings power and the credibility of the 2H supply-chain ramp.

Evidence & confidence

The article reports a same-day earnings miss plus explicit full-year guidance cuts (organic sales, pro forma EBIT, and EPS) and cites supply chain constraints as the driver.

Market effects

Signals ongoing aerospace and defense supply-chain bottlenecks, which can pressure peers’ near-term delivery and margin expectations.

US industrials and defense supply-chain sentiment likely pressured as investors generalize the constraint theme.

Could reinforce global aerospace production normalization delays if supplier qualification and tooling ramp timelines slip.

Counterpoint

Backlog growth and higher orders suggest demand remains intact; the guidance cut may be more about timing than structural deterioration.

Key entities

  • Honeywell Aerospace

    Aerospace and defense company reporting Q2 2026 results and cutting full-year outlook due to supply chain constraints.

  • Jim Currier

    CEO who said guidance is being aligned to supply chain capabilities at end of Q2.

Related articles

$HONLow

What Honeywell International (HON)'s Automation Leadership Shake-Up Means For Shareholders

Honeywell International (HON) announced leadership changes in its automation portfolio, appointing Billal Hammoud as President and CEO of Process Technology and Juan Picon to lead Building Automation. The company projects $22.5 billion revenue and $3.2 billion earnings by 2029, implying a 16.1% yearly revenue decline and a $5.1 billion earnings decrease from current levels. Analysts have mixed views on the impact of the planned spin-offs and leadership changes on the company's valuation and futu

$HONAHighAI 8/10

Honeywell Aerospace upgraded to Overweight by Morgan Stanley

Honeywell Aerospace (HONA) shares rose 5.5% after Morgan Stanley upgraded it to Overweight with a $205 price target. The firm cited attractive valuations at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, despite operational challenges and legal investigations. The company reported Q2 sales of $4.52B and an $18.2B backlog but cut full-year guidance due to supply chain issues.